

					
						November 21, 2017 - By Kurt Siggers
Among 29 analysts covering BP (NYSE:BP), 19 have Buy rating, 2 Sell and 8 Hold. Therefore 66% are positive. BP had 50 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Neutral” rating by BNP Paribas given on Wednesday, July 29. Piper Jaffray upgraded it to “Buy” rating and $4200 target in Friday, August 4 report. Evercore upgraded BP plc (ADR) (NYSE:BP) on Tuesday, November 3 to “Buy” rating. The firm has “Buy” rating given on Tuesday, September 8 by UBS. BNP Paribas reinitiated BP plc (ADR) (NYSE:BP) on Tuesday, October 11 with “Outperform” rating. On Monday, July 11 the stock rating was maintained by Jefferies with “Hold”. The rating was upgraded by Deutsche Bank on Wednesday, April 5 to “Buy”. BMO Capital Markets upgraded the shares of BP in report on Monday, September 18 to “Outperform” rating. The rating was upgraded by Societe Generale on Monday, January 30 to “Buy”. The firm has “Neutral” rating by Goldman Sachs given on Friday, September 11. See BP plc (ADR) (NYSE:BP) latest ratings:24/10/2017 Broker: Cowen & Co Rating: Hold New Target: $39.0 Maintain19/10/2017 Broker: Jefferies Rating: Hold New Target: $38.5 Maintain18/09/2017 Broker: BMO Capital Markets Old Rating: Market Perform New Rating: Outperform Upgrade29/08/2017 Broker: Jefferies Rating: Hold New Target: $36.14 Maintain24/08/2017 Broker: Piper Jaffray Rating: Buy New Target: $39.0 Maintain07/08/2017 Broker: PiperJaffray Old Rating: Neutral New Rating: Overweight New Target: $42 Upgrade04/08/2017 Broker: Piper Jaffray Rating: Buy New Target: $42.0000 Upgrade26/07/2017 Broker: Societe Generale Old Rating: Buy New Rating: Hold Downgrade13/07/2017 Broker: Jefferies Rating: Hold New Target: $35.9000 Maintain29/06/2017 Broker: Scotia Capital Rating: Buy New Target: $37.0000 The stock of Akers Biosciences Inc (NASDAQ:AKER) hit a new 52-week low and has $0.59 target or 3.00% below today’s $0.61 share price. The 9 months bearish chart indicates high risk for the $6.09M company. The 1-year low was reported on Nov, 21 by Barchart.com. If the $0.59 price target is reached, the company will be worth $182,700 less. About 24,840 shares traded. Akers Biosciences Inc (NASDAQ:AKER) has declined 16.22% since November 21, 2016 and is downtrending. It has underperformed by 32.92% the S&P500.BP p.l.c. is an integrated oil and gas company. The company has market cap of $129.55 billion. The Firm owns an interest in OJSC Oil Company Rosneft , an gas and oil company. It has a 33.38 P/E ratio. The Company’s divisions include Upstream, Downstream, Rosneft, and Other businesses and corporate. About 1.46 million shares traded. BP plc (ADR) (NYSE:BP) has risen 15.51% since November 21, 2016 and is uptrending. It has underperformed by 1.19% the S&P500.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.


		var data = "63557954";
		document.write('<ins class="adsbygoogle" style="background-color:transparent; display:inline-block;width:300px;height:600px;" data-ad-client="ca-pub-16900'+data+'675" data-ad-slot="7169126944"></ins>')
	
(adsbygoogle = window.adsbygoogle || []).push({});